Translational biomarkers in the era of precision medicine.
Artificial intelligence
Big data
Clinical trials
Omics
Translational biomarkers
Journal
Advances in clinical chemistry
ISSN: 2162-9471
Titre abrégé: Adv Clin Chem
Pays: United States
ID NLM: 2985173R
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
28
5
2021
pubmed:
29
5
2021
medline:
24
8
2021
Statut:
ppublish
Résumé
In this chapter we discuss the past, present and future of clinical biomarker development. We explore the advent of new technologies, paving the way in which health, medicine and disease is understood. This review includes the identification of physicochemical assays, current regulations, the development and reproducibility of clinical trials, as well as, the revolution of omics technologies and state-of-the-art integration and analysis approaches.
Identifiants
pubmed: 34044910
pii: S0065-2423(20)30091-3
doi: 10.1016/bs.acc.2020.08.002
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
191-232Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.